|
Cytorex wins
Second Prize in the Ideas 2005 Contest
|
Source: El Nacional – Friday 18 November 2005 A/18
(Caracas, Venezuela)
Stategy &
Business
DANIELA KAMMOUN
Ideas 2005:
692 Projects were presented
Cytorex de Venezuela S.A., a wholly Venezuelan owned subsidiary of Cytorex
Biosciences, Inc. , of Weston, Florida, won second place among all the
projects accepted in the IDEAS 2005 contest in Venezuela.
The third edition of the contest was
announced six months ago by Innovex, Cantv, Banco Mercantil, Siemens and
McKinsey & Company, and organized by the Law Firm of Ortega, Palacios
and Associates, and the Superior Institute for Administrative Studies
(IESA). 1,621 participants registered, and a total of 692 projects were
presented.
Calling for projects was sponsored by 18
companies, such as: Chevron, Sidor, Cadiven-Éxito, Empresas Polar, Procter
& Gamble, IBM, Cargill, El Nacional, Globovisión, Venoco, Acumuladores
Duncan, Fondo de Valores Inmobiliarios, Alfonzo Rivas, Envases Venezolanos,
Exxon Mobil & Inelectra.
Treatment for Cancer
The Cytorex team composed of William
Jimenez, Carlos M. García, and David Martucci deserved the second place of
the contest with their idea to produce two patent pending, low pH (acidic)
medications for the treatment of cancer and diseases of immunological
origin: Cytoreg® and CytoregUNO™, which work very fast in the treatment of
malignant tumors, acting selectively in cancer cells, inducing their death,
while leaving normal cells untouched.
Among the competitive advantages of the
products are low production cost, and low toxicity. The project requires
Five Billion Bolivars (2.3 Million US$) in its initial phase to develop the
compounds in Venezuela.
The organizers consider that the Ideas
2005 contest was very successful, and are preparing to organize Ideas 2006,
early next year.
For more information in the USA, please
contact: press@cytorex.com, or call
954-573-4006
|
The Top 50
Emerging Companies Voted by 100 Venture Capital Funds & Angel
Investors
FundingPost announces the winners of
the Second Annual Pitching Across America™, the largest Venture Capital
competition ever.
New York City (PRWEB) October 26,
2005 -- FundingPost (www.FundingPost.com) proudly announced today the
winning companies from its second annual Pitching Across America™
competition.
FundingPost, which has been introducing entrepreneurs to investors for
almost 5 years, established the competition in which 100 Venture
Capital Funds and Angel Investors participated as judges, voting on 300
business summaries from emerging companies nationwide. The largest
Venture Capital competition ever organized, this year’s Pitching Across
America was sponsored by Wolf Block and PRNewswire.
The emerging companies were evaluated on a scale of 1 to 10. Judging
criteria consisted of several key points including: the professionalism
of the written summary, current stage of development (customers,
revenue), competitive advantage and need in the marketplace,
feasibility for success, and whether the company is “VentureWorthy™.”
“We are delighted to have had another successful year of the Pitching
Across America competition. Again the response and the level of
interest from both the Venture and Angel community and the
entrepreneurs who participated was outstanding,” said Joe Rubin,
Director, FundingPost, “These entrepreneurs represent some of the most
promising emerging companies in the U.S. this year.”
"It was another great year for Pitching Across America and a real
testimony to FundingPost's value added service to the entrepreneur
& venture capital community,” said Josh M. Eudowe, Managing
Director, Santa Monica Partners Asset Management. “I reviewed some
great companies and look forward to learning of the winners.”
National Winner: CSX Fiber Networks, Virginia
Upon closing of a management buyout, CSX Fiber Networks is a $10mm
subsidiary of the Fortune 250 CSX Corporation.
CSX Fiber Networks, provides network and infrastructure services to the
largest US carriers including AT&T, MCI, Sprint, Cingular, Nextel
and Verizon and the US Government. The Company offers network
infrastructure deployment, financing, optimization, integration,
maintenance, and management throughout the continental US.
Leveraging its professional services, infrastructure deployment,
financing, and staffing capabilities, the company offers solutions that
significantly improve the price/performance of existing communications
networks enabling clients to better serve their customers while
improving operating economics. The design and delivery of these custom
infrastructure solutions leverages proprietary tools and assets,
including FiberSource, a knowledge and relationship base delivering
access to over 350,000 route miles of telecom network infrastructure
and over 530 metropolitan fiber networks nationwide.
Runner-Up: Controlled Semiconductor, Inc., Florida
ConSemi is manufacturer of LCD and Semiconductor Process Equipment. We
hold several patents in the industry ranging from photomask through
failure analysis. ConSemi launched our MRT (Mask Repair Tool) in 2004
and have sold several of these systems to the top LCD manufacturers in
the world. We have only 1 competitor in this industry and currently we
are 3-5 years ahead of them in technology. ConSemi has developed and
patented systems and processes in the production and test of the latest
leadframe process with our L2S2 product. We have also patented and will
be soon launching our FATcat System (Failure Analysis Tool). This
system has NO competitor and our only competition is a dangerous and
uncontrollable process using fuming nitric acid. ConSemi also has
several other products in R&D.
Runner-Up: Innovation Asset Group (IAG), Oregon
Innovation Asset Group, Inc. (IAG) is an Oregon c-corporation formed in
May of 2002. It has created a next-generation software system called
DECIPHER™ that enables companies, in real-time, to track and manage the
most valuable of their assets - their intellectual property (“IP”) and
other intangibles, related contracts, and how it all interrelates. Most
companies in our target market have no clear visibility of these
critical assets and the important information around them. As a result,
they are: (1) Not effectively managing their most valuable asset base;
(2) Exposed on the liability side more than necessary (3) Shipping (and
paying for) products & services after contracts have expired; (4)
Not collecting (or paying) royalties; (5) Using more administrative
personnel than necessary; and (6) Paying more money and spending more
time than necessary to roll up this information for compliance and
internal reporting purposes. We go directly at this problem with an
integrated solution. Having launched in late 2004 and already with
eleven customers from coast to coast and internationally, all of whom
are providing excellent feedback, IAG is positioned for a major land
grab in a significant market where exit transaction values are
extremely interesting.
State Winners:
CSX Fiber Networks, VA Papercutz, NY
Controlled Semiconductor, Inc., FL
EnerGenetics International, Inc., IA
Innovation Asset Group (IAG), OR
Aneurtonic, Inc., IL
Helissio Technologies Inc., FL
bioSAA, Inc., ME
Nano Interface Technology, Inc., VA
Wind Ventures Inc, WI
Elox Pharmaceuticals, Inc., MA
Cytorex
Biosciences Inc., FL
Cyclone Technologies LLP, FL
PACT Mfg., LLC, TN
Healthwave, Inc., NY
Azora LLC., TX
Parallel Computers Technology Inc., PA
Rent A Toll, Inc. (R.A.T.), TX
Accentus, LLC, NH
ConeTeq, LLC, MA
Nephrocelltech, LLC, UT
Prospect Strategies HCW Inc., NV
BAN-COMEX, CO
Futuristic Homes International, Inc., PA
Fourteen40 LLC, UT
The U.S. Condo Exchange, LLC, NY
Gridlogix, MO
Media Street, Inc., NY
LightSpace Technologies, Inc., CT
LandCell Systems, Inc, CA
Bridgeway Systems, Inc., CA
Dakov, NY
Psychology Online, Inc., CA
NETRIPLEX LLC, MA
HRexcelerator, IL
the ZorA toys company, LLC, MA
XtremePower Solutions, TX
Obvient Strategies, Inc., GA
Senscient, TX BRAŃA, FL
Nouvonet Corporation, CA
Avenger Engineering L.L.C., GA
Advanced Video Technology Corporation, CO
Porter Industries, OH
DataMind, MA
Jaysix USA Inc, VA
Broadband Learning Channel Inc., AZ
Aviation Safety Resources, NJ
Visiplex, Inc., IL
Step Up 4 Learning Systems, Inc., NC
Premiere Sponsor: Wolf Block
For more than 100 years, WolfBlock has helped entrepreneurial companies
to flourish. Some of our largest clients today were once among our
smallest clients. We have developed a proficiency in assisting
companies from conception through the venture capital stage and into a
public offering or exit sale. Our 300 lawyers have in-depth experience
in a broad range of industries and practice areas. With seven offices
in the Mid-Atlantic region covering the geographic corridor from New
York City to Washington, D.C., our smaller clients benefit from an
unusual combination: the sophisticated resources of a leading law firm
coupled with a culture of servicing the unique needs of rising
entrepreneurial companies. For more information, contact David Gitlin,
Partner, Corporate/Securities Chair, Wolf Block at (215) 977-2284.
Sponsor: PR Newswire
PR Newswire, the world's largest distributor of news releases, has over
40,000 members worldwide--many of which are small businesses,
entrepreneurs and start-ups. Our members benefit because their news
releases are accessible in the locations where the media goes to get
raw material for their stories. For additional information, please
contact 888-776-0942.
About FundingPost
For over four years FundingPost has worked with thousands of Angel and
Venture Capital Investors and Entrepreneurs. With over 2,500 CEOs and
400 Venture Funds attending events in 15 cities nationwide; a quarterly
Dealflow magazine; and a deal-exchange website that has, on average,
seen an introduction of an Investor to an Entrepreneur every business
day since its inception; FundingPost believes that it is important to
reach investors in every medium possible - both online and offline, and
is experiencing strong growth as the venture capital markets continue
to improve worldwide.
Note to editors: For additional information regarding the Pitching
Across America competition, its winners or the its judges, please
contact Aren Cohen at FundingPost who will facilitate any one-on-one
interviews with FundingPost, the winning companies or the Venture
Capital / Angel investors.
# # #
|
|
|
|
Aren Cohen
FUNDINGPOST
Visit Our Site
800-461-5509
Email us Here
|
|
|
The
Top 50 Emerging Companies voted by 140 Venture Capital Funds
& Angel Investors
|
Tuesday
December 14, 2004. 10:01 am ET
FundingPost
announces the winners of Pitching Across America(TM), the largest
Venture Capital competition ever
NEW YORK, Dec. 14 /PRNewswire-FirstCall/ -- FundingPost (http://www.FundingPost.com)
proudly announced today the winning companies from its first
annual Pitching Across America(TM) competition. FundingPost,
which has been introducing entrepreneurs to investors for almost
4 years, established the competition in which 140 Venture Capital
Funds and Angel Investors participated as judges, voting on 400
business summaries from emerging companies nationwide. This was the
largest Venture Capital competition ever organized, sponsored by
Wolf Block, Holland & Knight, TriNet, and PRNewswire.
The emerging companies were
evaluated on a scale of 1 to 10. Judging criteria consisted of
several key points including: the professionalism of the written
summary, current stage of development (customers, revenue),
competitive advantage and need in the marketplace, feasibility
for success, and whether the company is
"VentureWorthy(TM)."
"We were thrilled with the
response and the level of interest from both the Venture and
Angel community and the entrepreneurs who participated in
Pitching Across America(TM)," said Joe Rubin, Director,
FundingPost, "The investors voted these entrepreneurs as
some of the most promising emerging companies in the U.S."
"FundingPost's latest
Pitching Across America event was stellar," said Bill
Funcannon, Partner, OVP Venture Partners. "As a judge
representing the top-tier fund in the Pacific Northwest, I was
impressed by the 50 companies selected from a list of more than
400 entries. The start-ups chosen for the final round represented
real balance of companies between earlier- and later- stage
investing. There is a natural mix of winners from industry
segments based on market opportunities, and a balance between
risk and reward for venture capitalists and entrepreneurs
alike."
"The FundingPost
competition provided an efficient vehicle in which a busy VC
could quickly evaluate many investment opportunities," said
Daniel Penberthy, Rand Capital. "Much has been said about
entrepreneurs always having their 'elevator speech' ready. Well,
this is the 'elevator of today' and entrepreneurs need to be able
to summarize their business opportunity in a few paragraphs
instead of minutes, if they are to be successful in today's
fundraising environment.
FundingPost's competition
helped to accomplish this, and provided an introduction to three
new investment opportunities in my region."
National Winner: Remote Play,
Inc.
Founded to commercialize its
innovative RFID-Command & Control and RFID- Distance
Estimation wireless technology. This patented technology, called
SilverLink(TM), brings to market new and exciting products such
as ChildAlert(TM), a child-monitoring device. SilverLink(TM)'s
reliable technology provides the key ingredient in making these
new products possible. RPI has invested heavily in perfecting its
technology. SilverLink(TM) is the first to estimate distance
using RF in a robust manner. It is also the first to provide
multi-device discrimination with operating ranges over 1,000
feet. This capability is packaged into a miniature, low-cost,
low-power system that is especially suited to portable
applications.
State Winners: AdriaComm, Inc. (CA) Advanced Products Laboratories, Inc. (MN) AgeSpan, Inc. (OK) ALeNet, Inc. (FL) Appollonia Holdings Ltd. (CO) Axiolog, LLC (MI) Base One International Corporation (NY) BioSystem Development, LLC (WI) Canarys Automations Pvt.Ltd (WA) Computility (IA) CorAccess Systems (CO) Cytorex Biosciences Inc. (FL) Datacomm Management Sciences, Inc. (CT) DVForge, Inc. (TN) ElderMark Solutions, Inc. (MN) Elox Pharmaceuticals, Inc. (MA) Environmax,Inc. (UT) Estco Medical (MD) Ethidium Health Systems (PA) EZ Payment Solutions Inc. (AZ) Fat Spaniel Technologies, Inc. (CA) Freedom 4 Wireless, Inc. (FL) Gridlogix (MO) Healthwave, Inc. (NY) HiSpirit, LLC (ND) Ingenuus Software, Inc. (TX) Integrity Systems Ltd (MO) Loadstar Sensors, Inc. (CA) Mapping Solutions Inc. (OR) Montana Range, LLC (MT) New Earth Systems (UT) Obvient Strategies, Inc. (GA) On Time Medical Imaging (NM) OSI (NV) Parallel Computers Technology Inc. (PA) Porter Industries (OH) PPT Research, Inc. (PA) Professional Medical Associates, Inc. (KS) R & G Corporation (NY) Reinsurex (NY) RuralWest (WA) SaveItSafe Corp (TX) SDR Pharmaceuticals, Inc. (NJ) Soy Works Corporation (IL) Telesto-Secure (VA) The Benevolink Corporation (GA) Transaction Security, Inc. (MD) Ultrafit Preventive Medicine Centers (TX) YourWebPress.com (AR)
About FundingPost
For almost four years FundingPost
has worked with thousands of Angel and Venture Capital Investors
and Entrepreneurs. With over 3,000 CEOs and 500 Venture Funds
attending events in 15 cities nationwide, a quarterly Dealflow
magazine, and a deal-exchange Website that has, on average, seen
an introduction of an Investor to an Entrepreneur every business
day since its inception, FundingPost believes that it is
important to reach investors in every medium possible -- both
online and offline, and is experiencing strong growth as the venture
capital markets continue to improve worldwide.
Note to editors: Please contact
us for additional information or to schedule interviews with
FundingPost, any of the winning companies or the Venture Capital
/ Angel investors who participated as judges.
Media Contacts: For FundingPost.com Jeanne Achille The Devon Group (732) 542-2000, ext. 11 Jeanne@devonpr.com
|
|
|
|
Cytorex presents Murine
Melanoma Study Poster in Drug Discovery Boston
|
|
|
|
Weston, Florida August 2, 2004.
Cytorex Biosciences Inc. (Cytorex), a privately owned Biotechnology
company of Weston, Florida will present at the Drug Discovery
Conference on August 9, 2004. They will display a poster titled:
“Effect of Cytoreg® on Biomarkers in B16-F10 Murine Melanoma”. The
topic is the result of a pilot study performed by Dr. Manzur
Hassanhi, MD, Senior Research Scientist of Cytorex Biosciences
Inc., and Dr. Elzbieta Izbicka of the Institute of Drug Development
(IDD), San Antonio, Texas. Over 300 submitted poster abstracts were
reviewed by a poster review committee to determine the 150 posters
to be displayed at this year's conference. Poster topic categories
were chosen to mirror the topics covered in conference sessions.
|
|
|
|
This
coordinated effort will enable attendees to easily locate the
posters that relate to their areas of interest. All posters are
located inside the exhibit hall. “Cytoreg® is a novel anticancer
drug candidate which uses Hydrofluoric and Sulfuric acids as active
compounds. Upon completion of an in vivo study performed under a
separate agreement, formalin preserved lung tissue with B16-F10
metastases was provided for biomarker analysis. Quantitative
analysis of Bcl-2, Bax, Smac/Diablo, Survivin, Raf-1, and (P) Raf-1
was performed in thin sections from three representative tumor
metastases selected from the drug treatment group (.654 mg/mouse,
p.o., qd x 5 to end) and the corresponding control vehicle. Two
biomarkers (Bcl-2, Smac/Diablo) were below detection limits.
Cytoreg® induced some down regulation in Bax. Biomarkers levels of
Survivin and the (P) Raf-1/Raf-1 ratios were decreased in the
Cytoreg® treatment group. These finding are consistent with the
pro-apoptotic activity of the drug and the ability of Cytoreg® to
interfere with tumor signaling pathways in B16-F10 lung metastases”
according to Dr. Elzbieta Izbicka, Head of the Molecular Targets
Laboratory of IDD.
|
|
|
|
About
Cytorex Biosciences:
|
|
|
|
Cytorex
Biosciences Inc is a privately owned Biotechnology company in
Weston, Florida involved in the development of Cytoreg® and
CytoregUNO™, the company's novel therapeutic agents against cancer,
currently in pre-clinical phase. The company is in the initial
stage of a private offering. This is not to be construed as a
solicitation to offer or sell securities. For more information on
Cytorex Biosciences, visit the company’s website at
www.cytorex.com, or contact in the USA, Carlos M. Garcia, COO (954
573-4006), email: coo@cytorex.com
|
|
|
|
Download Poster Presented
at Drug Discovery Conference (Boston, Aug. 8-12)
|
|
Acrobat Reader
must be installed to read this document
|
|
|
|
Up
|
|
|
|
Cytorex
Biosciences Completes Cytotoxicity Testing With Its Anti-cancer
Compound Cytoreg®
|
|
|
|
For
Immediate Release
|
|
|
|
WESTON, Fla./EWORLDWIRE/July 7, 2004 --- Cytorex Biosciences Inc.
reports it has concluded cytotoxicity testing in cancer and healthy
cell cultures with its proprietary compound Cytoreg®, with
selective cytotoxicity activity against cancer cells, high
anti-oxidant and free radical stress capability. In healthy cells
tested at the same doses as cancer cells the cytotoxicity profile
is very low, making Cytoreg® a potential safe and effective first
line agent for the treatment of different cancer indications.
|
|
|
|
Testing performed by CeeTox Inc. in rat hepatoma (liver cancer)
cells, normal hepatocytes (liver), and normal kidney cells indicate
a distinctive cytotoxic activity of Cytoreg® in cancer cells.
"Normally I do not impress easily, but occasionally a project
has something truly large to offer, and I think Cytorex could be
one of these. In CeeTox, we are very impressed with the exciting
Cytoreg® data, for which we appreciate the opportunity to be part
of its success," indicated James M. McKim, Ph.D., President and
CEO of CeeTox Inc. of Kalamazoo, Mich.
|
|
|
|
"Results show a substantial difference in the levels of
inhibition of cancer cell growth, as well as of toxicity, which
reinforces the therapeutic potential of Cytoreg®. Cancer cells
present a non-coherent membrane regarding the receptors which make
them easily identifiable by Cytoreg®, as if they were naked or
without their regular 'shirts,' and Cytoreg® can detect them easily
to induce their death, cutting the proliferation and migration of
the same. Really, we are in front of a great innovation in the
fight against cancer," said Dr. James Kumi-Diaka, PhD, Biology
Professor and Cancer Research Scientist of Florida Atlantic
University in Davie, Fla.
|
|
|
|
Cytorex's preclinical data was evaluated by the National Cancer
Institute (NCI-Frederick) last year, and has allowed Cytorex to
reach a collaboration agreement with the NCI through an extensive
research and development program with Cytoreg® as potential
treatment for Glioblastoma Multiforme (brain cancer).
|
|
|
|
The Cytoreg® innovative and
breakthrough technology allows the pharmacological use of
compositions that combine organic acids and inorganic acids
(hydrofluoric and sulfuric, among others) to treat disease.
|
|
|
|
About
Cytorex Biosciences:
|
|
|
|
Cytorex Biosciences Inc is a privately owned Biotech company from
Weston involved in the development of Cytoreg® and CytoregUNO™, the
company's novel therapeutic agents against cancer currently in
pre-clinical phase. The company is in the initial stage of a
private offering. This is not to be construed as a solicitation to
offer or sell securities.
Download:
|
|
Evaluation of Cytoreg
Using In Vitro Toxicity Screening in Rat Hepatoma (H4IIE) Cells,
Normal Rat Kidney (NRK) Cells, and Rat Primary Hepatocytes
|
|
HTML: http://newsroom.eworldwire.com/wr/070704/10424.htm
|
|
PDF: http://newsroom.eworldwire.com/pdf/070704/10424.pdf
|
|
ONLINE
NEWSROOM: http://newsroom.eworldwire.com/2611.htm
|
|
LOGO: http://newsroom.eworldwire.com/2611.htm
|
|
|
|
CONTACT:
|
|
Carlos Garcia
|
|
Cytorex Biosciences, Inc, 4474
Weston Road No. 108
|
|
Weston, FL 33331
|
|
PHONE. 954-573-4006
|
|
FAX. 954-353-1258
|
|
EMAIL: info@cytorex.com
|
|
http://www.cytorex.com
|
|
|
|
William Jimenez
|
|
Cytorex
International, Inc. Edif Cámara de Comercio, Ave. 2 El
Milagro Ofic. No. 2
|
|
Maracaibo, Venezuela 4001A
|
|
PHONE. +58 -414-614-0226
|
|
EMAIL: wjimenez@cytorex.com
|
|
http://www.cytorex.com
|
|
|
|
KEYWORDS: Cancer, Oncology, Chemotherapy,
Cytotoxicity, Toxicity, Medicine, Cytorex.
|
|
SOURCE: Cytorex Biosciences, Inc.
|
|
|
Gathering
Of Angels In Pinehurst Features 2 North Carolina Companies
|
May
19th Event Hosted at Pine Needles Lodge Features Two NC Companies
and Three from Out-of-state
PINEHURST, N.C. 05-17-2004 -- The Gathering of Angels event in
Pinehurst will feature two promising high tech North Carolina
companies. Both Taper International, located in Southern Pines, and
DarPharma, a Chapel Hill-based biotech company, will make 20 minute
presentations to accredited investors at the Pine Needles Lodge.
The two N.C. companies will be joined by Cytorex Biosciences, a
Florida biotech company, Global Educational Technology, an
Atlanta info-tech company and Cord Partners, a biotech company from
Los Angeles, California.
“We were delighted with the response from companies for the
opportunity to present in Pinehurst,” said Tarby Bryant, the President
of Anasazi Capital, and the organizer of the Gathering of Angel
event. “Almost as soon as we posted the event on our web site, we
started getting inquiries from companies located across the United
States. We think the local angels and local economic development
professionals will really enjoy getting to meet these companies.”
The two North Carolina companies are engaged in different parts of
the high tech world. Taper International (http://www.betterhandcuffs.com/products.html),
makes high tech, products for law enforcement agencies. Their most
recent innovation are prisoner restraints that can not be picked by
prisoners. The process is patented and was developed in conjunction
with the assistance of many law enforcement officers.
DarPharma, (http://www.darpharma.com) is
focused on drug discovery and development in the area of dopamine
D1 agonists, the most promising CNS target for disorders including
Parkinson’s diseases, Schizophrenia, and Cocaine Abuse.
“I was happy that we were able to attract such promising North
Carolina companies,” said Tom Vass, the local partner who is
helping Bryant organize the angel events. “As a state, we need to
do everything possible to help native, small, high tech companies
obtain the growth capital they need to grow and prosper, and we
need to think of ways to introduce companies from the venture-rich
areas of the RTP to the venture-poor areas of the state.”
The Gathering of Angels will become a monthly event in Pinehurst,
and the next one is scheduled for June 16. There is no charge for
angels to attend, but pre-registration is required, either on the
Gathering of Angels web site or at www.corporateinvestment.net.
About Cytorex Biosciences:
Contact Mr. Carlos M. Garcia, CEO, 954 937 8519. www.cytorex.com.
Cytorex has developed a proprietary compound, Cytoreg®, which is
used to treat several types of cancer, including solid tumors,
blood cancers and lymphomas.
About Global Educational Technology. Contact Scott Shickler, CEO.
770 552 3173. www.getk12.com. GET creates
educational software applications that help educational institutions
comply with the accountability standards set by the “No Child Left
behind” Legislation, (H.R. 1).
About Cord Partners, Inc. Contact Matt Schissler, CEO. 310 443
4153. www.cordpartners.com. Cord Partners is stem cell
preervation company focused on blood storage technologies.
CONTACT:
TOM VASS, The Corporate Investment Center
919-821-2671
Tarby Bryant, The Gathering of Angels
505-982-3050
|
|
|
|
Up
|
|
|
|
Cytorex
Biosciences Inc. Develops a Ground Breaking Compound for
Potential Treatment of Cancer and Other Diseases of
Immunological Origin
|
|
|
|
April
29, 2003 07:02 PM US Eastern Time zone
|
|
|
|
WESTON, Fla.--(BUSINESS WIRE)--April 29, 2003--Cytorex Biosciences
Inc., (Cytorex) a South Florida biotechnology company, announced
today that they have developed a potential new treatment for cancer
and immunology related diseases based on the use of inorganic acids
such as Hydrofluoric Acid (HF), with low toxicity profile and a
high level of efficacy called Cytoreg®.
"This is a breakthrough
development in the pharmaceutical industry. This technology is
based on the use of inorganic acids as active compounds to treat
cancer and other diseases of immunological origin," indicated
Dr. Manzur Hassanhi, MD, PhD, Senior Medical Officer of Cytorex.
"This opens the door for the development of treatments for
other diseases," continued Dr. Hassanhi.
"We have so far used a
battery of in-vitro screening to test the Chemosensitivity of
Cytoreg® in human cancers. Results are promising with respect to
tumor response. Preliminary data suggest that Cytoreg® has
significant inhibitory and anti-proliferating effect on Human
breast, testicular, prostate and lung cancers, which were all the
cell lines tested at the time," indicated Dr. James
Kumi-Diaka, DVM, PhD, Professor of Biology at Florida Atlantic
University. "In terms of mechanism of action Cytoreg® induces
a selective and dose-dependent Apoptosis (programmed cell death) in
the target cells. These preliminary findings are of both diagnostic
and therapeutic significance. However, these results need to be
translated into in-vivo animal studies - to involve a large animal
population, in order to obtain statistically significant
results," concluded Dr. Kumi-Diaka.
"We treated five animals
with B-16 melanoma, using 1:100 dilution treatments daily. Tumors
in four of the animals did not grow, and then one that did appeared
to reach a state of no growth. There was no metastasis. A dose
response assay is required in a large group of animals. Preliminary
data suggest that Cytoreg® definitely is effective against
B-16," indicated Dr. Joseph Bryant, Director of the Animal
Model Studies Division of the Institute of Biotechnology at the
University of Maryland in Baltimore. Bryant performed a limited
animal study in B-16 melanoma cells in C57-BL mice.
Additional research with very
promising findings was conducted performing several in-vitro and
in-vivo assays between the years 2000 and 2002 with grants from
Cytorex to Rumbaugh-Goodwin Institute for Cancer Research, Inc., a
non-for-profit research facility located in Plantation, Florida.
Cytoreg® was developed by
Venezuelan Chemist Prof. David Martucci, CEO and Chief Scientific
Officer of Cytorex. Martucci has spent over 25 years in research
related to the use of inorganic acids for several applications
including "pharmacologically active buffered acid
solutions," with patent pending status in the United States
and Internationally. "This is an invention for humanity,"
said Martucci. "After we complete all the required testing by
FDA in the United States and Drug Approval regulators in other
countries, we expect to market our compounds at very reasonable
prices in order to make them available to people who cannot afford
the cost of cancer treatments available today," concluded
Martucci.
|
|
|
|
Ten Women &
Minority-Owned Technology Companies Selected to Present Their
Businesses at Statewide Technology Forum
|
|
NEW YORK & DELRAY BEACH,
Fla., Jun 13, 2002 (BUSINESS WIRE) --
BLG Ventures Announces
Publication of its "2002 Guide to Venture Capital &
Angel Investors for Women & Minorities"
Ten women and minority-owned
technology companies have been selected to make presentations
about their businesses at the 2nd Annual Technology Forum Series
Florida on June 18th at the Hilton Fort Lauderdale Airport Hotel.
Of the ten companies presenting, nine are Florida-based. The
Forum's theme is "Success Strategies for Finance to Grow
Your Business."
The Event Sponsor of the Forum
is Office Depot, Inc. (NYSE:ODP), the world's largest seller of
office products and services. Other sponsors include IBM, the
South Florida Business Journal, Mornington Consulting Partners,
Computer Coach, Winning Applications, Interpay and Web United.
The Technology Forum Series-Florida is the first of four such
events being sponsored by Office Depot held this year.
The Forum begins at 7:30 AM
with continental breakfast followed by a keynote address by
Monica Luechtefeld, Executive Vice President, E-Commerce, Office
Depot. Immediately following Ms. Luechtefeld's presentation, the
Forum will feature seminars led by companies such as IBM,
Computer Coach and Winning Applications, which will discuss how
the latest technology tools can help companies grow and expand
their business.
Topics include "Selecting
and implementing office software packages," "Business
and financial management systems" and "Firewall
security for business Web sites." The morning session will
conclude with a Best Practices panel featuring speakers from
Crossbow Ventures, Deloitte & Touche, Ruden McClosky Smith
& Schuster, CBIZ Human Resource Solutions and Marisela
Barcenas CPA.
During the afternoon session,
ten women and minority-owned technology companies will make
presentations to a distinguished panel of venture capitalists.
These companies are Conectron, Cytorex Biosciences,
eQualitativeResearch, Gardenia Systems, LocalO, netCRM, Neu Media
Technologies, RFM Broadcasting, TodoBebe.com and Traatek. These
companies, nine of which are based in central and south Florida,
represent a range of industries including information technology,
e-commerce and biotechnology.
BLG Ventures, the organizer of
the Forum, has also announced the publication of their first
book, BLG Ventures' 2002 Guide to Venture Capital and Angel
Investors for Woman and Minorities. The Guide contains a foreword
written by Monica Luechtefeld, the Executive Vice President of
E-Commerce at Office Depot. Highlights of the Guide include
profiles of fifty venture capital firms and angel investors
nationwide that have worked with BLG Ventures and which are
deemed to be "friendly" to women and minority companies
seeking capital.
The Guide also contains five
articles that offer advice to emerging growth companies seeking
capitainancial Considerations - How Much is My Company Worth?
-- Closing the Deal: Legal Issues
Associated with Raising Venture
Capital by Pamela
Robertson, Esq. & Suzette Recinos, Esq.,
Edwards & Angell
LLP (based in W. Palm Beach)
-- Employee vs. Independent Contractor
by Isabelle Levin,
American Express Tax
& Business Services
-- The Importance of Business Plan
Projections and Cash Flow
Statements in Growing
a Business by Isabelle Levin, American
Express Tax &
Business Services
-- PEOs: The Smart Entrepreneur's
Business Ally by Richard
Rawson, Administaff
In addition, the Guide includes
information about government and non-profit resources available
to entrepreneurs, a list of prominent attorneys and accountants
throughout the United States and sample legal and financial
documents.
"We're thrilled to offer
South Florida women and minority-owned businesses the opportunity
to interact and network with such a distinguished panel of
business thought leaders and venture capitalists. We are equally
excited about making our newly published Guide available for all
attendees to purchase. It is a wonderful resource for any
entrepreneur seeking valuable information about the process of
raising money to start a business. It also contains a wealth of
information that is useful for both business owners and aspiring
entrepreneurs," said Julian A. Barnes, President and COO of
BLG Ventures, Inc.
"Office Depot is committed
to providing knowledge and support to women and minority-owned
businesses. This year's agenda provides small businesses with a
wealth of information and resources that are aimed at helping
them to grow their businesses in today's competitive market. I am
pleased to be part of this year's Forum Series and I'm thrilled
to be in the company of such esteemed business leaders,"
said Monica Luechtefeld, Executive Vice President, E-Commerce for
Office Depot.
The Guide is currently
available at http://www.blgventures.com and the Guide will be
available at http://www.officedepot.com in late July and
available in Office Depot retail stores by Labor Day.
About Office Depot
No one sells more office
products to more customers in more countries through more
channels than Office Depot. As the largest seller of office
products around the world, the Company operates under the Office
Depot(R), Office Place(R), Viking Office Products(R), Viking
Direct(R) and 4Sure.com(R) brand names. As of March 30, 2002, Office
Depot operated 857 office supply superstores in the United States
and Canada, in addition to a national business-to-business
delivery network supported by 24 delivery centers, more than 60
local sales offices and 13 regional call centers. Furthermore, the
Company sells products and services in 17 countries outside of
the United States and Canada, including 30 office supply stores
in France and 11 in Japan that are owned and operated by the
Company; and 105 additional office supply stores under joint venture
and licensing agreements operating under the Office Depot name in
five foreign countries.
The Company operates an
award-winning U.S. Office Depot brand Web site at
http://www.officedepot.com where customers can access Office
Depot's low competitive prices seven days a week, twenty-four
hours a day. The Company also operates fifteen additional Web
sites, under the Office Depot and Viking Office Products names,
in the U.S. and nine international countries including: Austria,
Australia, France, Japan, Germany, Ireland, Italy, the
Netherlands and the United Kingdom.
Office Depot's common stock is
traded on the New York Stock Exchange under the symbol ODP and is
included in the S&P 500 Index.
About BLG Ventures
BLG Ventures, located in New
York City, is a marketing and consulting company for women and
minority-owned technology businesses located throughout the
United States. It hosts The Technology Forum Series, which
assists emerging growth companies in securing venture capital and
in growing their businesses.
PRESENTING COMPANIES Conectron Miami, FL Dr. Fernando Valverde 305/444-8286 Traatek Miami, FL Ms. Monique Traad 305/715-0396 TodoBebe.com Miami, FL Ms. Gillian Sandler 786/683-3777 Neu Media Technologies Coconut City, FL Mr. Sheldon Wright 954/422-8922 Cytorex Biosciences Coral Springs, FL Mr. David Martucci 954/575-4921 eQualitativeResearch Boca Raton, FL Ms. Renee Frengut 561/750-1787 Gardenia Systems Boca Raton Ms. Marni Robins 561/470-4999 LocalO Tampa Bay Ms. Jenni Criscenzo 813/258-4452 netCRM Tampa Bay, FL Mr. Ram Ajjarapu 813/971-8325 CONTACT: BLG Ventures, New York John Barnes, Julian Barnes, 212/462-4770 john@blgventures.com jab@blgventures.com or Office Depot, Delray Beach Lauren Garvey, 561/438-2895 lgarvey@officedepot.com URL: http://www.businesswire.com Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. Copyright (C) 2002 Business Wire. All rights reserved. |
|
|
Up
|
|
|
|
|
